Company / EPS (Diluted)
ENvue Medical, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$137.30
FY2025
5-year range
-$137.30 / -$0.42
FY2021-FY2025
Trend
-488.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -489% YoY in FY2025, a notable deviation from the 8-year average annual change of -226%.
Based on SEC 10-K filings.
-137.30 in FY2025.
Declined from $-3.84 to $-137.30 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 488.8% year-over-year.
- Peak eps (diluted) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$137.30 | -488.8% |
| FY2024 | -$23.32 | -507.3% |
| FY2023 | -$3.84 | - |
| FY2022 | - | - |
| FY2021 | -$0.42 | +49.4% |
| FY2020 | -$0.83 | -29.7% |
| FY2019 | -$0.64 | +45.3% |
| FY2018 | -$1.17 | -88.7% |
| FY2017 | -$0.62 | +24.4% |
| FY2016 | -$0.82 | +95.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026